P913 Intestinal Ultrasound in paediatric Crohn’s disease reduces the need for subsequent ileocolonoscopy

M Dorn-Rasmussen,T Boysen,C Jakobsen,V Wewer

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1043

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Approximately 20% of patients with Crohn's disease (CD) are diagnosed during childhood (pCD). At diagnosis, the vast majority (87%) of patients with pCD demonstrate severe disease activity.(1) Severe disease activity necessitates intensive treatment followed by frequent blood tests, faecal calprotectin tests, and endoscopic procedures. Ileocolonoscopy is burdensome for the patient, as bowel preparation and general anaesthesia are needed, and furthermore, the procedure is costly. In recent European guidelines for pCD management, Intestinal Ultrasound (IUS) is recommended for clinical follow-up. Our objective was to investigate the extent to which patients with pCD underwent subsequent endoscopy after having IUS performed during their follow-up regimen. Methods We conducted a retrospective descriptive cohort study, encompassing all patients with pCD at a referral center (Department of Paediatric and Adolescence Medicine, Copenhagen University Hospital, Amager and Hvidovre) who had undergone a minimum of one ultrasound examination over a 2.5-year period (May 1, 2021, to November 1, 2023). Results A total of 29 patients with pCD were enrolled in the study. Demographic data can be found in Table 1. The median follow-up since time of diagnosis was 40 months (interquartile range (IQR) 30-57). Time to the first IUS examination after diagnosis was median 28 months (IQR 13-49). The indications for IUS were as follows: Clinical suspicion of disease activity and/or elevated faecal calprotectin levels (66% of cases), evaluation of disease activity after initiating biologic therapy (10%), assessment of disease activity status (14%), suspicion of treatment failure (7%) and other indications (3%). Following the IUS procedure, 10% of patients subsequently underwent ileocolonoscopy, which was performed within 11, 14, or 53 days after IUS. Among the remaining 90% of patients, 14% underwent ileocolonoscopy 8-16 months after the IUS procedure, while 76% never had a repeat ileocolonoscopy performed after a median follow-up of 342 days (IQR 247-441) after IUS. Conclusion In 90% of patients with pCD IUS can be used to evaluate disease activity without the necessity for an ileocolonscopy in the subsequent 12 moths of follow up. References: (1) Wewer MD, Langholz E, Munkholm P, Bendtsen F, Benedict Seidelin J, Burisch J. Disease Activity Patterns of Inflammatory Bowel Disease-A Danish Nationwide Cohort Study 1995-2018. J Crohns Colitis. 2023 Apr 3;17(3):329-337. doi: 10.1093/ecco-jcc/jjac140. PMID: 36124895.

gastroenterology & hepatology

What problem does this paper attempt to address?

The paper primarily explores the use of Intestinal Ultrasound (IUS) to assess disease activity in pediatric Crohn's disease (CD) patients, aiming to reduce the need for subsequent ileocolonoscopy. Background information indicates that at the time of diagnosis, most pediatric Crohn's disease patients have severe conditions, necessitating frequent blood tests, fecal calprotectin tests, and endoscopic examinations. However, ileocolonoscopy is cumbersome and costly for patients as it requires bowel preparation and general anesthesia. In light of this, the research team retrospectively analyzed data from a group of pediatric Crohn's disease patients who had undergone at least one IUS examination. The study results showed that in most cases (90%), after assessing disease activity through IUS, patients did not need to undergo ileocolonoscopy within the following 12 months. This demonstrates the effectiveness of IUS as a monitoring tool and its potential clinical application value.